Platelet-derived growth factor inhibition-a new treatment of pulmonary hypertension in congenital diaphragmatic hernia?

Journal of Pediatric Surgery

Volumn 43, Issue 10, 2008, Pages 1928-1931

  Frenckner, Björn ^a   Broomé, Michael ^a   Lindström, Maria ^a   Radell, Peter ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Congenital diaphragmatic hernia; ECMO; Imatinib; PDGF inhibition; Pulmonary hypertension

Indexed keywords

ANTIBIOTIC AGENT; BOSENTAN; DIURETIC AGENT; ILOPROST; IMATINIB; MAGNESIUM; NITRIC OXIDE; SILDENAFIL;

ADD ON THERAPY; ARTICLE; CASE REPORT; DIAPHRAGM HERNIA; DRUG DOSE REDUCTION; DRUG WITHDRAWAL; ECHOCARDIOGRAPHY; GESTATIONAL AGE; HUMAN; HYPERCAPNIA; INFANT; LUNG PRESSURE; MALE; OXYGENATION; PRIORITY JOURNAL; PULMONARY HYPERTENSION; PULSE OXIMETRY; RESPIRATORY ACIDOSIS; THORAX RADIOGRAPHY;

ANOXIA; COMBINED MODALITY THERAPY; CONTINUOUS POSITIVE AIRWAY PRESSURE; DIURETICS; ENTERAL NUTRITION; EXTRACORPOREAL MEMBRANE OXYGENATION; HEART FAILURE; HERNIA, DIAPHRAGMATIC; HUMANS; HYPERTENSION, PULMONARY; ILOPROST; INFANT, NEWBORN; MALE; NITRIC OXIDE; PIPERAZINES; PROTEIN KINASE INHIBITORS; PURINES; PYRIMIDINES; RECEPTORS, PLATELET-DERIVED GROWTH FACTOR; SULFONAMIDES; SULFONES;

EID: 52949101780     PISSN: 00223468     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpedsurg.2008.07.022     Document Type: Article

References (13)

1. Boloker J., Bateman D.A., Wung J.T., et al. Congenital diaphragmatic hernia in 120 infants treated consecutively with permissive hypercapnea/spontaneous respiration/elective repair. J Pediatr Surg 37 (2002) 357-366
2. Clark R.H., Hardin W.D., Hirschl R.B., et al. Current surgical management of congenital diaphragmatic hernia: a report from the Congenital Diaphragmatic Hernia Study Group. J Pediatr Surg 33 (1998) 1004-1009
3. Frenckner B., Ehrén H., Granholm T., et al. Improved results in patients who have congenital diaphragmatic hernia using preoperative stabilization, extracorporeal membrane oxygenation, and delayed surgery. J Pediatr Surg 32 (1997) 1185-1189
4. Harting M.T., and Lally K.P. Surgical management of neonates with congenital diaphragmatic hernia. Semin Pediatr Surg 16 (2007) 109-114
5. Tenbrinck R., Gaillard J.L., Tibboel D., et al. Pulmonary vascular abnormalities in experimentally induced congenital diaphragmatic hernia in rats. J Pediatr Surg 27 (1992) 862-865
6. Mohseni-Bod H., and Bohn D. Pulmonary hypertension in congenital diaphragmatic hernia. Semin Pediatr Surg 16 (2007) 126-133
7. Perros F., Montani D., Dorfmuller P., et al. Am J Respir Crit Care Med (2008)
8. Humbert M., Monti G., Fartoukh M., et al. Platelet-derived growth factor expression in primary pulmonary hypertension: comparison of HIV seropositive and HIV seronegative patients. Eur Respir J 11 (1998) 554-559
9. Capdeville R., Buchdunger E., Zimmermann J., et al. Glivec (STI571, imatinib), a rationally developed, targeted anticancer drug. Nat Rev Drug Discov 1 (2002) 493-502
10. Schermuly R.T., Dony E., Ghofrani H.A., et al. Reversal of experimental pulmonary hypertension by PDGF inhibition. J Clin Invest 115 (2005) 2811-2821
11. Ghofrani H.A., Seeger W., and Grimminger F. Imatinib for the treatment of pulmonary arterial hypertension. N Engl J Med 353 (2005) 1412-1413
12. Souza R., Sitbon O., Parent F., et al. Long-term imatinib treatment in pulmonary arterial hypertension. Thorax 61 (2006) 736
13. Dillon P.W., Cilley R.E., Mauger D., et al. The relationship of pulmonary artery pressure and survival in congenital diaphragmatic hernia. J Pediatr Surg 39 (2004) 307-312 [Discussion 30]